Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer

類似資料

• Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
  著者:: Nam, Chang Hyun, 等
  出版事項: (2021)
• Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
  著者:: Kim, Ryul, 等
  出版事項: (2016)
• MET Receptor Tyrosine Kinase Regulates the Expression of Co-Stimulatory and Co-Inhibitory Molecules in Tumor Cells and Contributes to PD-L1-Mediated Suppression of Immune Cell Function
  著者:: Ahn, Hyun Kyung, 等
  出版事項: (2019)
• Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
  著者:: Kim, Su-Jung, 等
  出版事項: (2019)
• Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
  著者:: Ock, Chan-Young, 等
  出版事項: (2019)